Both in Biotechnology
Kyverna Therapeutics vs Ocugen
Over the past year KYTX returned −14.1% and OCGN returned −47.7%; their daily moves had a correlation of 0.30.
KYTX −14.1% OCGN −47.7%Growth of $1, one year, split-adjusted
| Metric | KYTX | OCGN |
|---|---|---|
| Price | $5.73 | $0.7900 |
| Market cap | $354.4M | $267.9M |
| Today | −1.88% | −3.08% |
| 1 month | −19.0% | −21.0% |
| 6 months | −36.0% | −52.7% |
| Year to date | −39.0% | −41.5% |
| 1 year | −19.7% | −49.7% |
| Revenue growth (YoY) | — | +8.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1671.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $174.4M | $15.9M |
| Dividend yield | — | — |
| Volatility (60d) | 56.7% | 69.2% |
| Short % of float | 26.2% | 31.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).